Compile Data Set for Download or QSAR

Found 1917 hits with Last Name = 'youngman' and Initial = 'm'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mu-type opioid receptor (Homo sapiens (Human))	BDBM364562 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-hydr...) Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)c3ccccc3)c2c1 |r,TLB:8:7:19:31.4.5| Show InChI InChI=1S/C28H32N2O3/c31-22-9-8-21-14-24-28-11-10-26(18-33-28,29-25(32)20-4-2-1-3-5-20)17-27(28,23(21)15-22)12-13-30(24)16-19-6-7-19/h1-5,8-9,15,19,24,31H,6-7,10-14,16-18H2,(H,29,32)/t24-,26?,27-,28-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0190	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg mem...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364547 ((4bR,6S,8aS,9R)-N-benzyl-11- (cyclopropylmethyl)-3...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NCc3ccccc3)c2c1 |r,TLB:9:8:20:31.5.6| Show InChI InChI=1S/C29H36N2O2/c1-32-24-10-9-23-15-26-29-12-11-27(20-33-29,30-17-21-5-3-2-4-6-21)19-28(29,25(23)16-24)13-14-31(26)18-22-7-8-22/h2-6,9-10,16,22,26,30H,7-8,11-15,17-20H2,1H3/t26-,27?,28-,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0260	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364552 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-meth...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)c3ccccc3)c2c1 |r,TLB:9:8:20:32.5.6| Show InChI InChI=1S/C29H34N2O3/c1-33-23-10-9-22-15-25-29-12-11-27(19-34-29,30-26(32)21-5-3-2-4-6-21)18-28(29,24(22)16-23)13-14-31(25)17-20-7-8-20/h2-6,9-10,16,20,25H,7-8,11-15,17-19H2,1H3,(H,30,32)/t25-,27?,28-,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0320	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364548 ((4bR,6S,8aS,9R)-N-(cyclohexylmethyl)-11- (cyclopro...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NCC3CCCCC3)c2c1 |r,TLB:9:8:20:31.5.6| Show InChI InChI=1S/C29H42N2O2/c1-32-24-10-9-23-15-26-29-12-11-27(20-33-29,30-17-21-5-3-2-4-6-21)19-28(29,25(23)16-24)13-14-31(26)18-22-7-8-22/h9-10,16,21-22,26,30H,2-8,11-15,17-20H2,1H3/t26-,27?,28-,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0520	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM364561 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-hydr...) Show SMILES CC(C)(C)C(=O)NC12CC[C@@]3(OC1)[C@H]1Cc4ccc(O)cc4[C@@]3(CCN1CC1CC1)C2 |r,TLB:26:25:10:21.15.14| Show InChI InChI=1S/C26H36N2O3/c1-23(2,3)22(30)27-24-8-9-26(31-16-24)21-12-18-6-7-19(29)13-20(18)25(26,15-24)10-11-28(21)14-17-4-5-17/h6-7,13,17,21,29H,4-5,8-12,14-16H2,1-3H3,(H,27,30)/t21-,24?,25-,26-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0560	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg mem...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364559 (4-Chloro-N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NS(=O)(=O)c3ccc(Cl)cc3)c2c1 |r,THB:9:8:20:34.5.6| Show InChI InChI=1S/C28H33ClN2O4S/c1-34-22-7-4-20-14-25-28-11-10-26(18-35-28,30-36(32,33)23-8-5-21(29)6-9-23)17-27(28,24(20)15-22)12-13-31(25)16-19-2-3-19/h4-9,15,19,25,30H,2-3,10-14,16-18H2,1H3/t25-,26?,27-,28-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0570	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364561 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-hydr...) Show SMILES CC(C)(C)C(=O)NC12CC[C@@]3(OC1)[C@H]1Cc4ccc(O)cc4[C@@]3(CCN1CC1CC1)C2 |r,TLB:26:25:10:21.15.14| Show InChI InChI=1S/C26H36N2O3/c1-23(2,3)22(30)27-24-8-9-26(31-16-24)21-12-18-6-7-19(29)13-20(18)25(26,15-24)10-11-28(21)14-17-4-5-17/h6-7,13,17,21,29H,4-5,8-12,14-16H2,1-3H3,(H,27,30)/t21-,24?,25-,26-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0590	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364562 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-hydr...) Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)c3ccccc3)c2c1 |r,TLB:8:7:19:31.4.5| Show InChI InChI=1S/C28H32N2O3/c31-22-9-8-21-14-24-28-11-10-26(18-33-28,29-25(32)20-4-2-1-3-5-20)17-27(28,23(21)15-22)12-13-30(24)16-19-6-7-19/h1-5,8-9,15,19,24,31H,6-7,10-14,16-18H2,(H,29,32)/t24-,26?,27-,28-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0620	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364549 ((4bR,6S,8aS,9R)-6-amino-11- (cyclopropylmethyl)-5,...) Show SMILES NC12CC[C@@]3(OC1)[C@H]1Cc4ccc(O)cc4[C@@]3(CCN1CC1CC1)C2 |r,TLB:20:19:4:15.9.8| Show InChI InChI=1S/C21H28N2O2/c22-19-5-6-21(25-13-19)18-9-15-3-4-16(24)10-17(15)20(21,12-19)7-8-23(18)11-14-1-2-14/h3-4,10,14,18,24H,1-2,5-9,11-13,22H2/t18-,19?,20-,21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.0960	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM151177 (BDBM151178 | US8987287, 7) Show SMILES Oc1ccc2C[C@@H]3[C@@H]4CC[C@@]5(C[C@]4(CCN3CC3CC3)c2c1)NC(=O)NC5=O |r| Show InChI InChI=1S/C22H27N3O3/c26-15-4-3-14-9-18-16-5-6-22(19(27)23-20(28)24-22)12-21(16,17(14)10-15)7-8-25(18)11-13-1-2-13/h3-4,10,13,16,18,26H,1-2,5-9,11-12H2,(H2,23,24,27,28)/t16-,18+,21-,22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.200	-55.4	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM151177 (BDBM151178 | US8987287, 7) Show SMILES Oc1ccc2C[C@@H]3[C@@H]4CC[C@@]5(C[C@]4(CCN3CC3CC3)c2c1)NC(=O)NC5=O |r| Show InChI InChI=1S/C22H27N3O3/c26-15-4-3-14-9-18-16-5-6-22(19(27)23-20(28)24-22)12-21(16,17(14)10-15)7-8-25(18)11-13-1-2-13/h3-4,10,13,16,18,26H,1-2,5-9,11-12H2,(H2,23,24,27,28)/t16-,18+,21-,22-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.230	-55.0	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM364559 (4-Chloro-N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NS(=O)(=O)c3ccc(Cl)cc3)c2c1 |r,THB:9:8:20:34.5.6| Show InChI InChI=1S/C28H33ClN2O4S/c1-34-22-7-4-20-14-25-28-11-10-26(18-35-28,30-36(32,33)23-8-5-21(29)6-9-23)17-27(28,24(20)15-22)12-13-31(25)16-19-2-3-19/h4-9,15,19,25,30H,2-3,10-14,16-18H2,1H3/t25-,26?,27-,28-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.290	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg mem...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50147083 (1-(4-tert-Butyl-benzyl)-3-isoquinolin-5-yl-urea | ...) Show SMILES CC(C)(C)c1ccc(CNC(=O)Nc2cccc3cnccc23)cc1 Show InChI InChI=1S/C21H23N3O/c1-21(2,3)17-9-7-15(8-10-17)13-23-20(25)24-19-6-4-5-16-14-22-12-11-18(16)19/h4-12,14H,13H2,1-3H3,(H2,23,24,25)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.300	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Binding affinity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane using [3H]-RTX as radioligand.				Bioorg Med Chem Lett 14: 3053-6 (2004) Article DOI: 10.1016/j.bmcl.2004.04.038 BindingDB Entry DOI: 10.7270/Q2FB52D6
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364557 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-meth...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)C3CC3)c2c1 |r,TLB:9:8:20:29.5.6| Show InChI InChI=1S/C26H34N2O3/c1-30-20-7-6-19-12-22-26-9-8-24(16-31-26,27-23(29)18-4-5-18)15-25(26,21(19)13-20)10-11-28(22)14-17-2-3-17/h6-7,13,17-18,22H,2-5,8-12,14-16H2,1H3,(H,27,29)/t22-,24?,25-,26-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.300	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM151184 (US8987287, 63) Show SMILES CN1C(=O)NC(=O)[C@@]11CC[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC2CC2)C1 |r| Show InChI InChI=1S/C23H29N3O4/c1-25-20(29)24-19(28)22(25)6-7-23(30)18-10-15-4-5-16(27)11-17(15)21(23,13-22)8-9-26(18)12-14-2-3-14/h4-5,11,14,18,27,30H,2-3,6-10,12-13H2,1H3,(H,24,28,29)/t18-,21-,22+,23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.300	-54.4	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364556 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-meth...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)C(C)(C)C)c2c1 |r,TLB:9:8:20:30.5.6| Show InChI InChI=1S/C27H38N2O3/c1-24(2,3)23(30)28-25-9-10-27(32-17-25)22-13-19-7-8-20(31-4)14-21(19)26(27,16-25)11-12-29(22)15-18-5-6-18/h7-8,14,18,22H,5-6,9-13,15-17H2,1-4H3,(H,28,30)/t22-,25?,26-,27-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.330	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM151183 (US8987287, 49) Show SMILES CCN1C(=O)NC(=O)[C@@]11CC[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC2CC2)C1 |r| Show InChI InChI=1S/C24H31N3O4/c1-2-27-21(30)25-20(29)23(27)7-8-24(31)19-11-16-5-6-17(28)12-18(16)22(24,14-23)9-10-26(19)13-15-3-4-15/h5-6,12,15,19,28,31H,2-4,7-11,13-14H2,1H3,(H,25,29,30)/t19-,22-,23+,24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.470	-53.2	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM151173 (US8987287, 3) Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@]5(CC[C@@]34O)NC(=O)NC5=O)c2c1 |r| Show InChI InChI=1S/C22H27N3O4/c26-15-4-3-14-9-17-22(29)6-5-21(18(27)23-19(28)24-21)12-20(22,16(14)10-15)7-8-25(17)11-13-1-2-13/h3-4,10,13,17,26,29H,1-2,5-9,11-12H2,(H2,23,24,27,28)/t17-,20-,21+,22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.600	-52.6	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364555 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-meth...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)c3ccc(Cl)cc3)c2c1 |r,TLB:9:8:20:33.5.6| Show InChI InChI=1S/C29H33ClN2O3/c1-34-23-9-6-21-14-25-29-11-10-27(18-35-29,31-26(33)20-4-7-22(30)8-5-20)17-28(29,24(21)15-23)12-13-32(25)16-19-2-3-19/h4-9,15,19,25H,2-3,10-14,16-18H2,1H3,(H,31,33)/t25-,27?,28-,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.600	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364558 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-meth...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)CC(F)(F)F)c2c1 |r,TLB:9:8:20:31.5.6| Show InChI InChI=1S/C25H31F3N2O3/c1-32-18-5-4-17-10-20-24-7-6-22(15-33-24,29-21(31)12-25(26,27)28)14-23(24,19(17)11-18)8-9-30(20)13-16-2-3-16/h4-5,11,16,20H,2-3,6-10,12-15H2,1H3,(H,29,31)/t20-,22?,23-,24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.660	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM364549 ((4bR,6S,8aS,9R)-6-amino-11- (cyclopropylmethyl)-5,...) Show SMILES NC12CC[C@@]3(OC1)[C@H]1Cc4ccc(O)cc4[C@@]3(CCN1CC1CC1)C2 |r,TLB:20:19:4:15.9.8| Show InChI InChI=1S/C21H28N2O2/c22-19-5-6-21(25-13-19)18-9-15-3-4-16(24)10-17(15)20(21,12-19)7-8-23(18)11-14-1-2-14/h3-4,10,14,18,24H,1-2,5-9,11-13,22H2/t18-,19?,20-,21-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.790	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg mem...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223336 (1-(1-(cyclopropylmethyl)-6-fluoro-1,2,3,4-tetrahyd...) Show SMILES Fc1ccc2C(CC3CC3)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:5.5,10.17| Show InChI InChI=1S/C24H24FN3O/c25-18-7-8-19-16(13-18)6-9-23(21(19)12-15-4-5-15)28-24(29)27-22-3-1-2-17-14-26-11-10-20(17)22/h1-3,7-8,10-11,13-15,21,23H,4-6,9,12H2,(H2,27,28,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.800	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50147069 (1-(4-Chloro-3-trifluoromethyl-benzyl)-3-isoquinoli...) Show SMILES FC(F)(F)c1cc(CNC(=O)Nc2cccc3cnccc23)ccc1Cl Show InChI InChI=1S/C18H13ClF3N3O/c19-15-5-4-11(8-14(15)18(20,21)22)9-24-17(26)25-16-3-1-2-12-10-23-7-6-13(12)16/h1-8,10H,9H2,(H2,24,25,26)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.800	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Binding affinity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane using [3H]-RTX as radioligand.				Bioorg Med Chem Lett 14: 3053-6 (2004) Article DOI: 10.1016/j.bmcl.2004.04.038 BindingDB Entry DOI: 10.7270/Q2FB52D6
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM151184 (US8987287, 63) Show SMILES CN1C(=O)NC(=O)[C@@]11CC[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC2CC2)C1 |r| Show InChI InChI=1S/C23H29N3O4/c1-25-20(29)24-19(28)22(25)6-7-23(30)18-10-15-4-5-16(27)11-17(15)21(23,13-22)8-9-26(18)12-14-2-3-14/h4-5,11,14,18,27,30H,2-3,6-10,12-13H2,1H3,(H,24,28,29)/t18-,21-,22+,23-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.860	-56.1	n/a	n/a	n/a	n/a	n/a	7.4	50
Purdue Pharma L.P. US Patent					Assay Description mu-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Per...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM364548 ((4bR,6S,8aS,9R)-N-(cyclohexylmethyl)-11- (cyclopro...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NCC3CCCCC3)c2c1 |r,TLB:9:8:20:31.5.6| Show InChI InChI=1S/C29H42N2O2/c1-32-24-10-9-23-15-26-29-12-11-27(20-33-29,30-17-21-5-3-2-4-6-21)19-28(29,25(23)16-24)13-14-31(26)18-22-7-8-22/h9-10,16,21-22,26,30H,2-8,11-15,17-20H2,1H3/t26-,27?,28-,29-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.930	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg mem...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM151175 (US8987287, 5) Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@]5(CNC(=O)N5)CC[C@@]34O)c2c1 |r| Show InChI InChI=1S/C22H29N3O3/c26-16-4-3-15-9-18-22(28)6-5-20(13-23-19(27)24-20)12-21(22,17(15)10-16)7-8-25(18)11-14-1-2-14/h3-4,10,14,18,26,28H,1-2,5-9,11-13H2,(H2,23,24,27)/t18-,20+,21-,22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	0.940	-51.5	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364546 ((4bR,6S,8aS,9R)-11-(cyclopropylmethyl)- 3,6-dihydr...) Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(O)CC[C@@]34OC5=O)c2c1 |r,TLB:8:7:20:24.4.5,THB:23:22:14.15:19.18| Show InChI InChI=1S/C21H25NO4/c23-15-4-3-14-9-17-21-6-5-20(25,18(24)26-21)12-19(21,16(14)10-15)7-8-22(17)11-13-1-2-13/h3-4,10,13,17,23,25H,1-2,5-9,11-12H2/t17-,19-,20?,21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.950	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223313 (1-(1-(4-bromobenzyl)-6-methoxy-1,2,3,4-tetrahydron...) Show SMILES COc1ccc2C(Cc3ccc(Br)cc3)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:6.6,15.22| Show InChI InChI=1S/C28H26BrN3O2/c1-34-22-10-11-23-19(16-22)7-12-27(25(23)15-18-5-8-21(29)9-6-18)32-28(33)31-26-4-2-3-20-17-30-14-13-24(20)26/h2-6,8-11,13-14,16-17,25,27H,7,12,15H2,1H3,(H2,31,32,33)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223314 (1-(1-(4-(trifluoromethyl)benzyl)-6-fluoro-1,2,3,4-...) Show SMILES Fc1ccc2C(Cc3ccc(cc3)C(F)(F)F)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:5.5,17.24| Show InChI InChI=1S/C28H23F4N3O/c29-21-9-10-22-18(15-21)6-11-26(24(22)14-17-4-7-20(8-5-17)28(30,31)32)35-27(36)34-25-3-1-2-19-16-33-13-12-23(19)25/h1-5,7-10,12-13,15-16,24,26H,6,11,14H2,(H2,34,35,36)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50147080 (3-(4-tert-Butyl-phenyl)-N-isoquinolin-5-yl-acrylam...) Show SMILES CC(C)(C)c1ccc(\C=C\C(=O)Nc2cccc3cnccc23)cc1 Show InChI InChI=1S/C22H22N2O/c1-22(2,3)18-10-7-16(8-11-18)9-12-21(25)24-20-6-4-5-17-15-23-14-13-19(17)20/h4-15H,1-3H3,(H,24,25)/b12-9+	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Antagonistic activity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane, as inhibition of agonist-induced intracellular [C...				Bioorg Med Chem Lett 14: 3053-6 (2004) Article DOI: 10.1016/j.bmcl.2004.04.038 BindingDB Entry DOI: 10.7270/Q2FB52D6
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50147067 (1-[2-(4-tert-Butyl-phenyl)-ethyl]-3-isoquinolin-5-...) Show SMILES CC(C)(C)c1ccc(CCNC(=O)Nc2cccc3cnccc23)cc1 Show InChI InChI=1S/C22H25N3O/c1-22(2,3)18-9-7-16(8-10-18)11-14-24-21(26)25-20-6-4-5-17-15-23-13-12-19(17)20/h4-10,12-13,15H,11,14H2,1-3H3,(H2,24,25,26)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Binding affinity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane using [3H]-RTX as radioligand.				Bioorg Med Chem Lett 14: 3053-6 (2004) Article DOI: 10.1016/j.bmcl.2004.04.038 BindingDB Entry DOI: 10.7270/Q2FB52D6
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50147063 (1-Isoquinolin-5-yl-3-(4-trifluoromethoxy-benzyl)-u...) Show SMILES FC(F)(F)Oc1ccc(CNC(=O)Nc2cccc3cnccc23)cc1 Show InChI InChI=1S/C18H14F3N3O2/c19-18(20,21)26-14-6-4-12(5-7-14)10-23-17(25)24-16-3-1-2-13-11-22-9-8-15(13)16/h1-9,11H,10H2,(H2,23,24,25)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Binding affinity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane using [3H]-RTX as radioligand.				Bioorg Med Chem Lett 14: 3053-6 (2004) Article DOI: 10.1016/j.bmcl.2004.04.038 BindingDB Entry DOI: 10.7270/Q2FB52D6
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50147077 (1-(3,5-Bis-trifluoromethyl-phenyl)-3-isoquinolin-5...) Show SMILES FC(F)(F)c1cc(NC(=O)Nc2cccc3cnccc23)cc(c1)C(F)(F)F Show InChI InChI=1S/C18H11F6N3O/c19-17(20,21)11-6-12(18(22,23)24)8-13(7-11)26-16(28)27-15-3-1-2-10-9-25-5-4-14(10)15/h1-9H,(H2,26,27,28)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Antagonistic activity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane, as inhibition of agonist-induced intracellular [C...				Bioorg Med Chem Lett 14: 3053-6 (2004) Article DOI: 10.1016/j.bmcl.2004.04.038 BindingDB Entry DOI: 10.7270/Q2FB52D6
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364553 (N-((4bR,6S,8aS,9R)-11- (cyclopropylmethyl)- 3-meth...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)CCc3ccccc3)c2c1 |r,TLB:9:8:20:34.5.6| Show InChI InChI=1S/C31H38N2O3/c1-35-25-11-10-24-17-27-31-14-13-29(21-36-31,32-28(34)12-9-22-5-3-2-4-6-22)20-30(31,26(24)18-25)15-16-33(27)19-23-7-8-23/h2-6,10-11,18,23,27H,7-9,12-17,19-21H2,1H3,(H,32,34)/t27-,29?,30-,31-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.58	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223328 (1-(1-benzyl-5-chloro-1,2,3,4-tetrahydronaphthalen-...) Show SMILES Clc1cccc2C(Cc3ccccc3)C(CCc12)NC(=O)Nc1cccc2cnccc12 |w:6.6,14.20| Show InChI InChI=1S/C27H24ClN3O/c28-24-10-5-9-21-22(24)12-13-26(23(21)16-18-6-2-1-3-7-18)31-27(32)30-25-11-4-8-19-17-29-15-14-20(19)25/h1-11,14-15,17,23,26H,12-13,16H2,(H2,30,31,32)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223330 (1-(1-allyl-6-fluoro-1,2,3,4-tetrahydronaphthalen-2...) Show SMILES Fc1ccc2C(CC=C)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:5.5,9.15| Show InChI InChI=1S/C23H22FN3O/c1-2-4-20-18-9-8-17(24)13-15(18)7-10-22(20)27-23(28)26-21-6-3-5-16-14-25-12-11-19(16)21/h2-3,5-6,8-9,11-14,20,22H,1,4,7,10H2,(H2,26,27,28)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223331 (1-(1-benzyl-6-bromo-1,2,3,4-tetrahydronaphthalen-2...) Show SMILES Brc1ccc2C(Cc3ccccc3)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:5.5,13.20| Show InChI InChI=1S/C27H24BrN3O/c28-21-10-11-22-19(16-21)9-12-26(24(22)15-18-5-2-1-3-6-18)31-27(32)30-25-8-4-7-20-17-29-14-13-23(20)25/h1-8,10-11,13-14,16-17,24,26H,9,12,15H2,(H2,30,31,32)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223338 (1-(1-(4-(trifluoromethyl)benzyl)-6-methoxy-1,2,3,4...) Show SMILES COc1ccc2C(Cc3ccc(cc3)C(F)(F)F)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:6.6,18.25| Show InChI InChI=1S/C29H26F3N3O2/c1-37-22-10-11-23-19(16-22)7-12-27(25(23)15-18-5-8-21(9-6-18)29(30,31)32)35-28(36)34-26-4-2-3-20-17-33-14-13-24(20)26/h2-6,8-11,13-14,16-17,25,27H,7,12,15H2,1H3,(H2,34,35,36)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223321 (1-(1-(3-chlorobenzyl)-6-methoxy-1,2,3,4-tetrahydro...) Show SMILES COc1ccc2C(Cc3cccc(Cl)c3)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:6.6,15.22| Show InChI InChI=1S/C28H26ClN3O2/c1-34-22-9-10-23-19(16-22)8-11-27(25(23)15-18-4-2-6-21(29)14-18)32-28(33)31-26-7-3-5-20-17-30-13-12-24(20)26/h2-7,9-10,12-14,16-17,25,27H,8,11,15H2,1H3,(H2,31,32,33)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM151183 (US8987287, 49) Show SMILES CCN1C(=O)NC(=O)[C@@]11CC[C@@]2(O)[C@H]3Cc4ccc(O)cc4[C@@]2(CCN3CC2CC2)C1 |r| Show InChI InChI=1S/C24H31N3O4/c1-2-27-21(30)25-20(29)23(27)7-8-24(31)19-11-16-5-6-17(28)12-18(16)22(24,14-23)9-10-26(19)13-15-3-4-15/h5-6,12,15,19,28,31H,2-4,7-11,13-14H2,1H3,(H,25,29,30)/t19-,22-,23+,24-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	2.28	-53.5	n/a	n/a	n/a	n/a	n/a	7.4	50
Purdue Pharma L.P. US Patent					Assay Description mu-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Per...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM364560 (1-Chlorophenyl-3-((4bR,6S,8aS,9R)-11- (cyclopropyl...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)Nc3ccc(Cl)cc3)c2c1 |r,TLB:9:8:20:34.5.6| Show InChI InChI=1S/C29H34ClN3O3/c1-35-23-9-4-20-14-25-29-11-10-27(18-36-29,32-26(34)31-22-7-5-21(30)6-8-22)17-28(29,24(20)15-23)12-13-33(25)16-19-2-3-19/h4-9,15,19,25H,2-3,10-14,16-18H2,1H3,(H2,31,32,34)/t25-,27?,28-,29-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	2.56	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 μg membrane protein (recomb...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223333 (1-(1-benzyl-6-methoxy-1,2,3,4-tetrahydronaphthalen...) Show SMILES COc1ccc2C(Cc3ccccc3)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:6.6,14.21| Show InChI InChI=1S/C28H27N3O2/c1-33-22-11-12-23-20(17-22)10-13-27(25(23)16-19-6-3-2-4-7-19)31-28(32)30-26-9-5-8-21-18-29-15-14-24(21)26/h2-9,11-12,14-15,17-18,25,27H,10,13,16H2,1H3,(H2,30,31,32)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM364560 (1-Chlorophenyl-3-((4bR,6S,8aS,9R)-11- (cyclopropyl...) Show SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC5(CC[C@@]34OC5)NC(=O)Nc3ccc(Cl)cc3)c2c1 |r,TLB:9:8:20:34.5.6| Show InChI InChI=1S/C29H34ClN3O3/c1-35-23-9-4-20-14-25-29-11-10-27(18-36-29,32-26(34)31-22-7-5-21(30)6-8-22)17-28(29,24(20)15-23)12-13-33(25)16-19-2-3-19/h4-9,15,19,25H,2-3,10-14,16-18H2,1H3,(H2,31,32,34)/t25-,27?,28-,29-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3.51	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
GNF					Assay Description Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.), with 5 mg mem...				J Med Chem 50: 4255-9 (2007) BindingDB Entry DOI: 10.7270/Q2222X2R
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM151175 (US8987287, 5) Show SMILES Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@]5(CNC(=O)N5)CC[C@@]34O)c2c1 |r| Show InChI InChI=1S/C22H29N3O3/c26-16-4-3-15-9-18-22(28)6-5-20(13-23-19(27)24-20)12-21(22,17(15)10-16)7-8-25(18)11-14-1-2-14/h3-4,10,14,18,26,28H,1-2,5-9,11-13H2,(H2,23,24,27)/t18-,20+,21-,22-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	3.55	-52.3	n/a	n/a	n/a	n/a	n/a	7.4	50
Purdue Pharma L.P. US Patent					Assay Description mu-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Per...				US Patent US8987287 (2015) BindingDB Entry DOI: 10.7270/Q24F1PFT
					More data for this Ligand-Target Pair
B2 bradykinin receptor (Homo sapiens (Human))	BDBM50126226 (3-[5-(4-Cyano-benzoyl)-1-methyl-1H-pyrrol-2-yl]-N-...) Show SMILES CN(C(=O)CCc1ccc(C(=O)c2ccc(cc2)C#N)n1C)c1ccc(Cl)c(COc2cccc3ccc(C)nc23)c1Cl Show InChI InChI=1S/C34H28Cl2N4O3/c1-21-7-10-23-5-4-6-30(33(23)38-21)43-20-26-27(35)15-17-28(32(26)36)40(3)31(41)18-14-25-13-16-29(39(25)2)34(42)24-11-8-22(19-37)9-12-24/h4-13,15-17H,14,18,20H2,1-3H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Binding affinity towards human bradykinin receptor B2				Bioorg Med Chem Lett 13: 1341-4 (2003) BindingDB Entry DOI: 10.7270/Q2HM57T1
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223335 (1-(1-benzyl-1,2,3,4-tetrahydronaphthalen-2-yl)-3-(...) Show SMILES O=C(NC1CCc2ccccc2C1Cc1ccccc1)Nc1cccc2cnccc12 |w:12.14,3.2| Show InChI InChI=1S/C27H25N3O/c31-27(29-25-12-6-10-21-18-28-16-15-23(21)25)30-26-14-13-20-9-4-5-11-22(20)24(26)17-19-7-2-1-3-8-19/h1-12,15-16,18,24,26H,13-14,17H2,(H2,29,30,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223340 (1-(1-benzyl-6-fluoro-1,2,3,4-tetrahydronaphthalen-...) Show SMILES Fc1ccc2C(Cc3ccccc3)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:5.5,13.20| Show InChI InChI=1S/C27H24FN3O/c28-21-10-11-22-19(16-21)9-12-26(24(22)15-18-5-2-1-3-6-18)31-27(32)30-25-8-4-7-20-17-29-14-13-23(20)25/h1-8,10-11,13-14,16-17,24,26H,9,12,15H2,(H2,30,31,32)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223323 (1-(isoquinolin-5-yl)-3-(3-phenyl-2-(4-(trifluorome...) Show SMILES FC(F)(F)c1ccc(cc1)C(CNC(=O)Nc1cccc2cnccc12)Cc1ccccc1 |w:10.11| Show InChI InChI=1S/C26H22F3N3O/c27-26(28,29)22-11-9-19(10-12-22)21(15-18-5-2-1-3-6-18)17-31-25(33)32-24-8-4-7-20-16-30-14-13-23(20)24/h1-14,16,21H,15,17H2,(H2,31,32,33)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50223315 (1-(6-fluoro-1-(thiophen-2-ylmethyl)-1,2,3,4-tetrah...) Show SMILES Fc1ccc2C(Cc3cccs3)C(CCc2c1)NC(=O)Nc1cccc2cnccc12 |w:5.5,12.19| Show InChI InChI=1S/C25H22FN3OS/c26-18-7-8-20-16(13-18)6-9-24(22(20)14-19-4-2-12-31-19)29-25(30)28-23-5-1-3-17-15-27-11-10-21(17)23/h1-5,7-8,10-13,15,22,24H,6,9,14H2,(H2,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [3H]RTX from human TRPV1 expressed in HEK293 cells				Bioorg Med Chem Lett 17: 6160-3 (2007) Article DOI: 10.1016/j.bmcl.2007.09.036 BindingDB Entry DOI: 10.7270/Q28G8KFT
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1 (Homo sapiens (Human))	BDBM50147060 (3-[4-(1,1-Dimethyl-propyl)-phenyl]-N-isoquinolin-5...) Show SMILES CCC(C)(C)c1ccc(CCC(=O)Nc2cccc3cnccc23)cc1 Show InChI InChI=1S/C23H26N2O/c1-4-23(2,3)19-11-8-17(9-12-19)10-13-22(26)25-21-7-5-6-18-16-24-15-14-20(18)21/h5-9,11-12,14-16H,4,10,13H2,1-3H3,(H,25,26)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Binding affinity towards human vanilloid receptor subtype 1 expressed in HEK293 cell membrane using [3H]-RTX as radioligand.				Bioorg Med Chem Lett 14: 3053-6 (2004) Article DOI: 10.1016/j.bmcl.2004.04.038 BindingDB Entry DOI: 10.7270/Q2FB52D6
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1917 total )  |  Next  |  Last  >>

Jump to: